The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

Background Synaptic loss is a major hallmark of Alzheimer’s disease (AD). Disturbed organisation of large-scale functional brain networks in AD might reflect synaptic loss and disrupted neuronal communication. The medical food Souvenaid, containing the specific nutrient combination Fortasyn Connect, is designed to enhance synapse formation and function and has been shown to improve memory performance in patients with mild AD in two randomised controlled trials. Objective To explore the effect of Souvenaid compared to control product on brain activity-based networks, as a derivative of underlying synaptic function, in patients with mild AD. Design A 24-week randomised, controlled, double-blind, parallel-group, multi-country study. Participants 179 drug-naïve mild AD patients who participated in the Souvenir II study. Intervention Patients were randomised 1∶1 to receive Souvenaid or an iso-caloric control product once daily for 24 weeks. Outcome In a secondary analysis of the Souvenir II study, electroencephalography (EEG) brain networks were constructed and graph theory was used to quantify complex brain structure. Local brain network connectivity (normalised clustering coefficient gamma) and global network integration (normalised characteristic path length lambda) were compared between study groups, and related to memory performance. Results The network measures in the beta band were significantly different between groups: they decreased in the control group, but remained relatively unchanged in the active group. No consistent relationship was found between these network measures and memory performance. Conclusions The current results suggest that Souvenaid preserves the organisation of brain networks in patients with mild AD within 24 weeks, hypothetically counteracting the progressive network disruption over time in AD. The results strengthen the hypothesis that Souvenaid affects synaptic integrity and function. Secondly, we conclude that advanced EEG analysis, using the mathematical framework of graph theory, is useful and feasible for assessing the effects of interventions. Trial registration Dutch Trial Register NTR1975.

[1]  E. Goldensohn,et al.  The EEG in centenarians. , 1976, Electroencephalography and clinical neurophysiology.

[2]  R. Wurtman,et al.  Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus , 2007, Brain Research.

[3]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[4]  C. Hoogenraad,et al.  Synapse Pathology in Psychiatric and Neurologic Disease , 2010, Current neurology and neuroscience reports.

[5]  R. Benedictus,et al.  Erratum to “Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells” [Neuroscience 134 (2005) 207–214] , 2005, Neuroscience.

[6]  R. Wurtman,et al.  Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets , 2011, British Journal of Nutrition.

[7]  Jaeseung Jeong.  EEG dynamics in patients with Alzheimer's disease , 2004, Clinical Neurophysiology.

[8]  G. Cecchi,et al.  Scale-free brain functional networks. , 2003, Physical review letters.

[9]  R. Wurtman,et al.  Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats , 2007, Journal of Molecular Neuroscience.

[10]  Martin Koller,et al.  A neuropsychological test battery for use in Alzheimer disease clinical trials. , 2007, Archives of neurology.

[11]  A. Bokde,et al.  Assessing neuronal networks: Understanding Alzheimer's disease , 2009, Progress in Neurobiology.

[12]  R. Wurtman,et al.  Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Wurtman,et al.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses , 2008, Alzheimer's & Dementia.

[14]  W. M. van der Flier,et al.  Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory , 2009, BMC Neuroscience.

[15]  A. Engel,et al.  Beta-band oscillations—signalling the status quo? , 2010, Current Opinion in Neurobiology.

[16]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[17]  H. Bays.  Safety considerations with omega-3 fatty acid therapy. , 2007, The American journal of cardiology.

[18]  Ernst Fernando Lopes Da Silva Niedermeyer,et al.  Electroencephalography, basic principles, clinical applications, and related fields , 1982 .

[19]  J. A. Almendral,et al.  Reorganization of Functional Networks in Mild Cognitive Impairment , 2011, PloS one.

[20]  Maarten van Steen,et al.  Graph Theory and Complex Networks: An Introduction , 2010 .

[21]  D. Salmon,et al.  The neuropsychological profile of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[22]  R. Benedictus,et al.  Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells , 2005, Neuroscience.

[23]  B. Lawlor,et al.  Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study , 2003, British Journal of Nutrition.

[24]  C. Stam,et al.  The organization of physiological brain networks , 2012, Clinical Neurophysiology.

[25]  Xiao-Jing Wang.  Neurophysiological and computational principles of cortical rhythms in cognition. , 2010, Physiological reviews.

[26]  A. Leuchter,et al.  Relationships between EEG Coherence and Neuropsychological Tests in Dementia , 1995, Clinical EEG.

[27]  S. Rombouts,et al.  Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity , 2010, PloS one.

[28]  Young-Min Park,et al.  Decreased EEG synchronization and its correlation with symptom severity in Alzheimer's disease , 2008, Neuroscience Research.

[29]  P. Kamphuis,et al.  A multi nutrient concept to enhance synapse formation and function: science behind a medical food for Alzheimer’s disease , 2011 .

[30]  C. Stam,et al.  Small-world networks and functional connectivity in Alzheimer's disease. , 2006, Cerebral cortex.

[31]  D. L. Schomer,et al.  Niedermeyer's Electroencephalography: Basic Principles, Clinical Applications, and Related Fields , 2012 .

[32]  Cornelis J. Stam,et al.  Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease , 2012, NeuroImage.

[33]  Z. Duan,et al.  GRAPH THEORY AND COMPLEX NETWORKS , 2008 .

[34]  A. Pérez-Villalba.  Rhythms of the Brain, G. Buzsáki. Oxford University Press, Madison Avenue, New York (2006), Price: GB £42.00, p. 448, ISBN: 0-19-530106-4 , 2008 .

[35]  Cornelis J. Stam,et al.  Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer's Disease , 2012, PLoS Comput. Biol..

[36]  P. Scheltens,et al.  Utility of imaging for nutritional intervention studies in Alzheimer's disease. , 2011, European journal of pharmacology.

[37]  W. Harris.  Expert opinion: omega-3 fatty acids and bleeding-cause for concern? , 2007, The American journal of cardiology.

[38]  D. Kromhout,et al.  Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. , 2007, The American journal of clinical nutrition.

[39]  R. Wurtman,et al.  Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats , 2008, Behavioural Brain Research.

[40]  Alan C. Evans,et al.  Neuronal Networks in Alzheimer's Disease , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[41]  G. Ramakers,et al.  Neuronal network formation in human cerebral cortex. , 2005, Progress in brain research.

[42]  Erol Başar,et al.  A review of gamma oscillations in healthy subjects and in cognitive impairment. , 2013, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[43]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[44]  R. Benedictus,et al.  Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]. , 2005, Neuroscience.

[45]  G. Patton,et al.  Low serum docosahexaenoic acid is a significant risk factor for alzheimer’s dementia , 2007, Lipids.

[46]  George E. Marzloff,et al.  Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally , 2006, Brain Research.

[47]  C. Stam,et al.  Phase lag index: Assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources , 2007, Human brain mapping.

[48]  A. Brun,et al.  Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[49]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[50]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[51]  R. Ihl,et al.  Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type , 2005, Journal of Neural Transmission / General Section JNT.

[52]  R. Wurtman,et al.  Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats , 2012, Nutrition & Metabolism.

[53]  E. Bullmore,et al.  Human brain networks in health and disease , 2009, Current opinion in neurology.

[54]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[55]  P. Kamphuis,et al.  Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.

[56]  O. Sporns,et al.  Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.

[57]  R. Wurtman,et al.  Use of phosphatide precursors to promote synaptogenesis. , 2009, Annual review of nutrition.

[58]  K. Charlton,et al.  Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. , 2004, The journal of nutrition, health & aging.

[59]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[60]  M. Posner,et al.  Localization of cognitive operations in the human brain. , 1988, Science.

[61]  M K Habib,et al.  Dynamics of neuronal firing correlation: modulation of "effective connectivity". , 1989, Journal of neurophysiology.

[62]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[63]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[64]  Francesco Rundo,et al.  Fronto-parietal coupling of brain rhythms in mild cognitive impairment: A multicentric EEG study , 2006, Brain Research Bulletin.

[65]  R. Reitan.  The relation of the trail making test to organic brain damage. , 1955, Journal of consulting psychology.

[66]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[67]  P. Kamphuis,et al.  A specific multi‐nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro , 2012, Journal of neurochemistry.

[68]  C. J. Stam,et al.  Functional connectivity patterns of human magnetoencephalographic recordings: a ‘small-world’ network? , 2004, Neuroscience Letters.

[69]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[70]  G. Sandini,et al.  Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[71]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[72]  E. Whitham,et al.  Scalp electrical recording during paralysis: Quantitative evidence that EEG frequencies above 20Hz are contaminated by EMG , 2007, Clinical Neurophysiology.

[73]  J. G. van Dijk,et al.  EEG correlates in the spectrum of cognitive decline , 2007, Clinical Neurophysiology.

[74]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.